Medacta Group SA is expanding its MyImplant platform from established shoulder applications to hip reconstruction, providing a custom-fit solution to support surgeons in managing complex cases, particularly where fixation may be challenging due to extensive bone loss. 

MyImplant is built on Medacta’s longstanding expertise in 3D planning, additive manufacturing, and patient-matched solutions—a foundation developed over more than 15 years through continuous innovation and real-world clinical application. Central to this ecosystem is Medacta’s advanced 3D Metal technology and the MySolutions Personalized Ecosystem, which together enable precise anatomical restoration and optimized biomechanics. This experience has helped produce implants designed to support long-term stability and, ultimately, to improve patient quality of life.

The new MyImplant solution for hip procedures was unveiled during the recent M.O.R.E. International Hip Symposium in Paris (March 12–13), an event that also celebrated more than 20 years of the Versafitcup and Quadra systems, supported by the AMIS surgical technique and HIGHCROSS polyethylene. This milestone reflects Medacta’s commitment to advancing MIS hip replacement through innovation in implants, minimally invasive techniques, advanced materials, and tailored education. This expertise, backed by strong clinical evidence and long-term outcomes, underpins the development of MyImplant for complex acetabular reconstruction.

While MyImplant applications in shoulder surgery primarily focus on glenoid reconstruction, the new hip solution aims to address complex acetabular reconstruction, further expanding the Medacta Hip Revision Platform and strengthening the company’s ability to support surgeons in managing high-complexity cases. 

“In my experience, the advanced level of customization of MyImplant contributes to simplifying the management of complex acetabular defects in a relevant and effective manner,” said Dr. med. Alois Franz, Marien Kliniken Siegen, Germany.  

Advanced software, combined with patient CT scans, enables precise preoperative planning and surgical simulation, allowing surgeons to analyze the patient’s anatomy in detail and plan the procedure before entering the operating room. This approach helps surgeons achieve the desired implant positioning, fit, and stability. The resulting design is translated into a 3D-printed monobloc customized implant, manufactured as a single titanium component, combined with a dedicated set of patient-matched instruments, including bone models, trial implant, and drilling guides.

“The ability to plan the procedure in detail and tailor the implant to the patient’s specific anatomy is a key advantage when addressing complex cases, enabling more precise reconstruction and increasing confidence in achieving stable, accurate results,” said Dr. Alexandre Lädermann, Hôpital de La Tour, Switzerland.

The implant is produced using 3D Metal, Medacta’s in-house additive manufacturing technology, engineered to replicate the natural porosity of bone, achieve intrinsic high friction, and provide a precise scratch-fit¹ with the surrounding bone. This porous structure is designed to facilitate integration between the implant and the native bone. Together with patient-specific screw configuration, customized trajectories, and positions that may reduce the need for intraoperative adjustments, 3D Metal contributes to improving primary stability. 

Beyond the custom-fit implant itself, MyImplant provides surgeons with support throughout the custom implant workflow. Medacta’s engineering team collaborates closely with surgeons during the design phase to incorporate clinical input and develop patient-matched implants and instruments tailored to each case. 

“Working with the Medacta engineering team was a truly collaborative experience. The accuracy of the screw mapping, the implant fit, and the quality of communication throughout the process were remarkable. MyImplant represents a meaningful advancement in the management of major acetabular revision surgery,” added Wayne G. Paprosky, M.D., Rush University Medical Center.

Medacta continues to invest in medical education to support the adoption of technologies such as MyImplant, through dedicated educational initiatives and scientific events. Medacta specializes in the design, production, and distribution of personalized, sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta improves patient care and well-being through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in more than 90 countries.

Reference
¹ www.medacta.com/EN/3d-metal.